Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: Medroxyprogesterone progesterone acetate (MPA)|DRUG: Medroxyprogesterone with Cyclophosphamide + Methotrexate
Sponsor: Indiana University
Collaborators: Translational Breast Cancer Research Consortium